Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Additional Metadata
Persistent URL	doi.org/10.1038/s41375-020-0707-2, hdl.handle.net/1765/123931
Journal	Leukemia
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pfeifer, H., Cazzaniga, G., van der Velden, V., Cayuela, J.-M., Schäfer, B. (B.), Spinelli, O., … Ottmann, O. G. (2020). Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0). Leukemia. doi:10.1038/s41375-020-0707-2

Publication